Nexera UC/s

Article

Sponsored Content

Shimadzu’s new Nexera UC/s(SFC/UHPLC switching system) allows measurements by liquid chromatography (LC) and supercritical fluid chromatography (SFC) on a single system. Switching between SFC and LC enables rapid screening for optimum separation conditions resulting in improved analytical efficiency. Through a newly-released upgrade kit, UHPLC units already installed can be upgraded to the Nexera UC/s, thereby decreasing investment cost for the additional SFC system.

 

For more information please visit www.shimadzu.eu

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content
Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Patrick Lavery
May 15th 2025
Article

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Pharmacy, hands and prescription medicine for customer with paper bag for healthcare, drugs and pharmaceutical. Closeup of a pharmacist or medical worker with person in drugstore for retail service | Image Credit: © Azee Jacobs/peopleimages.com - stock.adobe.com

Trump Issues Executive Order Aimed at Reducing Prescription Drug Prices for US Patients

Patrick Lavery
May 13th 2025
Article

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Site Logo

Improve Your Efficiency in Production

Fedegari
May 13th 2025
Article

Example of how we offer creative and interesting solutions to our customers to improve efficiency in production.

Site Logo

Be Proactive Not Reactive

Fedegari
May 13th 2025
Article

We want to inform our customers that we have an excellent tech center available to assist them to develop together tailor-made solutions and personalized technologies, solve problems and complete hands-on training on our machines.